Treatment Outcomes of Hospitalized Patients With Inflammatory Bowel Disease at a Tertiary Care Center in Nepal: A Cross‐Sectional Study
JCC Plus · 2026-07 · 1 (4)
DOI: 10.1002/jcc5.70046 ↗Kurz gefasst
Fachartikel in der Zeitschrift JCC Plus, online erschienen am 03.06.2026. Verfasst von Ajay Kumar Yadav und 5 weiteren Autor:innen. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Hospitalization is a critical phase in the management of inflammatory bowel disease (IBD). Hospitalized patients with IBD have varied outcomes despite advances in therapy. This study examined the treatment patterns and short‐term clinical outcomes of hospitalized patients with IBD.
Methods
A prospective cross‐sectional study was conducted, analyzing data from all patients with IBD admitted to the Department of Gastroenterology at Bir Hospital, National Academy of Medical Sciences, Kathmandu, Nepal, from May 2024 to September 2025. Statistical data were analyzed using IBM SPSS Statistics 23 (SPSS Inc., Chicago, Illinois, USA). Continuous measurements were presented as mean ± standard deviation (SD) for normally distributed data and median (range; interquartile range, IQR) for data that were not normally distributed, whereas categorical measurements were presented as frequencies and percentages.
Results
Overall, patients with IBD constituted 1.6% ( n = 37) of all admissions to the gastroenterology ward for any indication. Among these, 25 (68%) patients had ulcerative colitis (UC) and 12 (32%) had Crohn's disease (CD). Thirty five (95%) of in‐hospital patients with IBD showed a clinical response to treatment. Among these patients, 24 (65%) responded to conventional therapies, with a higher response rate among those with UC, whereas 9 (27%) required advanced therapies such as biologics and Janus kinase inhibitors. Surgical intervention, specifically urgent colectomy, led to a clinical response in two patients. In‐hospital mortality occurred in two (5%) of the patients, with one death each in the UC and CD groups.
Conclusions
Most (2/3rd) hospitalized patients with IBD responded to conventional therapy; one third required advanced therapy or surgery. In‐hospital mortality was high at 5%, probably related to delayed diagnosis, limited access to advanced treatments, and disease‐related complications.
Zitieren
APA
Yadav, A. K., Basnet, B. K., Shrestha, R., Khanal, A., Shrestha, M., & Poudel, M. S. (2026). Treatment Outcomes of Hospitalized Patients With Inflammatory Bowel Disease at a Tertiary Care Center in Nepal: A Cross‐Sectional Study. JCC Plus, 1(4). https://doi.org/10.1002/jcc5.70046
Vancouver
Yadav AK, Basnet BK, Shrestha R, Khanal A, Shrestha M, Poudel MS. Treatment Outcomes of Hospitalized Patients With Inflammatory Bowel Disease at a Tertiary Care Center in Nepal: A Cross‐Sectional Study. JCC Plus. 2026;1(4). doi:10.1002/jcc5.70046
BibTeX
@article{Yadav2026,
author = {Yadav, Ajay Kumar and Basnet, Bhupendra Kumar and Shrestha, Ramila and Khanal, Ajit and Shrestha, Milan and Poudel, Mukesh Sharma},
title = {Treatment Outcomes of Hospitalized Patients With Inflammatory Bowel Disease at a Tertiary Care Center in Nepal: A Cross‐Sectional Study},
journal = {JCC Plus},
year = {2026},
volume = {1},
number = {4},
doi = {10.1002/jcc5.70046}
}
EUVIMED